Daiichi Sankyo definition

Daiichi Sankyo means: Daiichi Sankyo Co., Ltd., its directors, officers, employees, agents, representatives, successors, and assigns; and its joint ventures, subsidiaries, divisions, groups and affiliates in each case controlled by Daiichi Sankyo Co., Ltd, and the respective directors, officers, employees, agents, representatives, successors, and assigns of each.
Daiichi Sankyo has the meaning ascribed thereto in the Preamble.
Daiichi Sankyo is an ideal partner for denosumab,” said Xxxxx Xxxxxx, Chairman and CEO of Amgen. “Daiichi Sankyo is uniquely positioned to bring this potential therapy to patients with a wide spectrum of bone-related diseases in Japan.” “Daiichi Sankyo is thrilled to partner with a world leader in biotechnology to gain access to this important antibody product,” said Xxxxxxx Xxxxx, President and CEO of Daiichi Sankyo. “We believe that denosumab has the potential to be a first-in-class, leading product in Japan for multiple indications within Daiichi Sankyo’s therapeutic areas of focus. Denosumab’s potential applicability in oncology makes it an important part of the foundation for our growing oncology business.” Daiichi Sankyo has a full range of commercial capabilities, including in the primary care and hospital settings, a track record of successful large, first-in-class product launches and the financial strength to ensure appropriate investment in the product. About Denosumab Denosumab is a fully human monoclonal antibody that targets RANK Ligand and is being investigated for its potential to prevent and treat a broad range of bone loss conditions including osteoporosis, bone metastases, treatment-induced bone loss, multiple myeloma and bone erosions in rheumatoid arthritis. Denosumab is the first late-stage investigational therapy that specifically inhibits RANK Ligand, an essential mediator of the cells that break down bone. About Amgen Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. To learn more about our pioneering science and our vital medicines, visit xxx.xxxxx.xxx. About Daiichi Sankyo Company, Limited DAIICHI SANKYO COMPANY, LIMITED was established in September 2005 as the joint holding company for the DAIICHI SANKYO Group by means of a stock transfer. Business integration has proceeded steadily since then, and the integration process was completed in April 2007 with the merger of Sankyo Co. Ltd. and Daiichi...

Examples of Daiichi Sankyo in a sentence

  • In September 2016, Daiichi Sankyo entered a cross-licensing and collaboration agreement with Zymeworks Inc.

  • Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or pub- lication of this article: Maddalena Lettino: speaker andconsulting fees for AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Aspen, Pfizer, Eli Lilly, Daiichi Sankyo, Sanofi.

  • In June 2019, Daiichi Sankyo obtained approval for manufacturing and marketing in Japan for the treatment of adults with relapsed or refractory FLT3-ITD acute myeloid leukemia (AML).

  • We take necessary measures to manage and protect personal information, business partner information as well as other confidential information of Daiichi Sankyo and others.

  • In our exclusive territories, we pay Daiichi Sankyo a royalty specific to these territories.

  • This revenue includes revenue generated by Daiichi Sankyo, Inc., and American Regent, Inc.- At Daiichi Sankyo, Inc., sales of Welchol declined.- In August 2019, Daiichi Sankyo, Inc.

  • Total comprehensive income decreased by ¥22.0 billion, or 14.9% year on year, to ¥125.6 billion.- Total comprehensive income decreased mainly because the tax liabilities related to business restructuring of Daiichi Sankyo and its consolidated subsidiaries (“the Group”), which was carried out in the past fiscal year, were reversed in the same period of the previous fiscal year.[Revenue by Geographic Area]‌Primary revenue by geographic area is as follows.

  • The companies in the Japanese Pharmaceutical Group are as follows:Astellas LtdChugai Pharma Europe Ltd Daiichi Sankyo UK Ltd Eisai LtdKowa Pharmaceutical Europe Co Ltd Mitsubishi Pharma Europe Ltd Otsuka Pharmaceutical Europe Ltd Shiongi LtdSunovion Pharmaceuticals Europe Ltd (formerly Dainippon Sumitomo) Takeda UK LtdApril 2014, received £3,000 for 2014/15, paid direct to charity.

  • All royalties paid to Daiichi Sankyo and the third-party manufacturer are recorded in cost of sales.

  • In addition, Daiichi Sankyo launched the transdermal long-acting treatment for cancer pain FENTANYL CITRATE TAPE for 1 day “DAIICHI SANKYO” in June, thereby enhancing the lineup of opioid analgesics to better meet the various needs of cancer pain treatment.- Daiichi Sankyo decided in July 2018 that the domestic manufacturing and sales approvals for 41 long-listed products that Daiichi Sankyo and its subsidiary Daiichi Sankyo Espha Co., Ltd.

Related to Daiichi Sankyo

  • Novartis shall have the meaning set forth in the Preamble.

  • Merck has the meaning set forth in the preamble.

  • GSK will have the meaning set forth in the Preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • ISIS means the department’s individualized services information system.

  • Pfizer shall have the meaning set forth in the preamble.

  • Elan means Elan Corp and its Affiliates.

  • Shire means Shire of Augusta Margaret River

  • PTC means the tax credit for electricity produced from certain renewable generation resources described in Section 45 of the Internal Revenue Code of 1986, as it may be amended or supplemented from time to time.

  • Lilly has the meaning set forth in the Preamble.

  • Collaboration Technology means the Collaboration Know-How and the Collaboration Patents.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • mg means milligram.

  • DSM means the most current edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association.

  • ONYX means Onyx Acceptance Corporation, and its successors.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • NPS means nominal pipe size.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • haemophilia means an inheritable disease, usually affecting only male but transmitted by women to their male children, characterised by loss or impairment of the normal clotting ability of blood so that a minor would may result in fatal bleeding;

  • UBC means the University of British Columbia.

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Halogen means one of the chemical elements chlorine, bromine or iodine.

  • orphan means a child who has no surviving parent caring for him or her;

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Licensed Compound means [***].